Toward the next generation of negative symptom assessments: The collaboration to advance negative symptom assessment in schizophrenia

Schizophrenia Bulletin

Volumn 37, Issue 2, 2011, Pages 291-299

  Blanchard, Jack J ^a   Kring, Ann M ^b   Horan, William P ^c   Gur, Raquel ^d  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

assessment; negative symptoms; schizophrenia

Indexed keywords

ANHEDONIA; ARTICLE; BLUNTED AFFECT; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT INTERVIEW FOR NEGATIVE SYMPTOMS; COLLABORATION TO ADVANCE NEGATIVE SYMPTOM ASSESSMENT IN SCHIZOPHRENIA; CONCEPT FORMATION; CONSENSUS DEVELOPMENT; HUMAN; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEGATIVE SYNDROME; PRIORITY JOURNAL; PSYCHOPATHY; RELIABILITY; VALIDITY;

AFFECTIVE SYMPTOMS; APHASIA; COGNITION DISORDERS; CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; COST OF ILLNESS; EDUCATION; HUMANS; INTERVIEW, PSYCHOLOGICAL; NATIONAL INSTITUTE OF MENTAL HEALTH (U.S.); PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; RESEARCH; SCHIZOPHRENIA; SCHIZOPHRENIC LANGUAGE; SCHIZOPHRENIC PSYCHOLOGY; UNITED STATES;

EID: 79952122958     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbq104     Document Type: Article

References (62)

1. Kirkpatrick B, Fenton W, Carpenter WT, Marder SR. The NIMH-MATRICS consensus statement on negative symptoms. Schizophr Bull. 2006;32:296-303.
2. Alphs LD, Summerfelt A, Lann H, Muller RJ. The negative symptom assessment: a new instrument to assess negative symptoms in schizophrenia. Psychopharmacol Bull. 1989;25:159-163. (Pubitemid 19273137)
3. Andreasen NC. Negative symptoms in schizophrenia: definition and reliability. Arch Gen Psychiatry. 1982;39:784-788. (Pubitemid 12090301)
4. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261-271.
5. Kirkpatrick B, Buchanan RW, McKenney PD, Alphs LD, Carpenter W. The schedule for the deficit syndrome: an instrument for research in schizophrenia. Psychiatry Res. 1989;30:119-123. (Pubitemid 20005923)
6. Bellack AS, Morrison RL, Wixted JT, Mueser KT. An analysis of social competence in schizophrenia. Br J Psychiatry. 1990;156:809-818. (Pubitemid 20207091)
7. Bellack AS, Morrision RL, Mueser KT, Wade J. Social competence in schizoaffective disorder, bipolar disorder, and negative and non-negative schizophrenia. Schizophr Res. 1989;2:391-401. (Pubitemid 20006408)
8. Breier A, Schreiber JL, Dyer J, Pickar D. National Institute of Mental Health longitudinal study of chronic schizophrenia: prognosis and predictors of outcome. Arch Gen Psychiatry. 1991;48:239-246.
9. Fenton WS, McGlashan TH. Natural history of schizophrenia subtypes. II. Positive and negative symptoms and longterm course. Arch Gen Psychiatry. 1991;48:978-986.
10. Kelley ME, van Kammen DP, Allen DN. Empirical validation of primary negative symptoms: independence from effects of medication and psychosis. Am J Psychiatry. 1999;156:406-411. (Pubitemid 29124162)
11. Mueser KT, Bellack AS, Morrison RL, Wixted JT. Social competence in schizophrenia: premorbid adjustment, social skill, and domains of functioning. J Psychiatr Res. 1990;24(1):51-63. (Pubitemid 20334679)
12. Ho BC, Nopoulos P, Flaum M, Arndt S, Andreasen NC. Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life. Am J Psychiatry. 1998;155:1196-1201. (Pubitemid 28402512)
13. Milev P, Ho B-C, Arndt S, Andreasen NC. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am J Psychiatry. 2005;162:495-506. (Pubitemid 40343916)
14. Siegel SJ, Irani F, Brensinger CM, et al. Prognostic variables at intake and long-term level of function in schizophrenia. Am J Psychiatry. 2006;163:433-441. (Pubitemid 44469385)
15. Perlick DA, Rosenheck RA, Kaczynski R, Swartz MS, Canive JM, Lieberman JA. Components and correlates of family burden in schizophrenia. Psychiatr Serv. 2006;57:1117-1125. (Pubitemid 44204904)
16. Weisman AG, Nuechterlein KH, Goldstein MJ, Snyder KS. Controllability perceptions and reactions to symptoms of schizophrenia: a within-family comparison of relatives with high and low expressed emotion. J Abnorm Psychol. 2000;109:167-171. (Pubitemid 30155420)
17. Blanchard JJ, Cohen AS. The structure of negative symptoms within schizophrenia: implications for assessment. Schizophr Bull. 2006;32:238-245.
18. Murphy BP, Chung Y-C, Park T-W, McGorry PD. Pharmacological treatment of primary negative symptoms in schizophrenia: a systematic review. Schizophr Res. 2006;88:5-25. (Pubitemid 44693240)
19. Leucht S, Pitschel-Walz G, Abraham D, Kissling W. Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials. Schizophr Res. 1999;35:51-68. (Pubitemid 29023554)
20. Montgomery SA, Zwieten-Boot B. ECNP consensus meeting. Negative, depressive, and cognitive symptoms of schizophrenia. Nice, March 2004. Eur Neuropsychopharmacol. 2006;17:70-77. (Pubitemid 44802759)
21. Leucht S, Arbter D, Engel R, Kissling W, Davis J. How effective are second-generation antipsychotic drugs? A metaanalysis of placebo-controlled trials. Mol Psychiatry. 2009;14:429-447.
22. Laughren T, Levin R. Food and Drug Administration perspective on negative symptoms in schizophrenia as a target for a drug treatment claim. Schizophr Bull. 2006;32:220-222.
23. Andreasen NC. The Scale for the Assessment of Negative Symptoms (SANS). Iowa City: The University of Iowa; 1984.
24. Sayers SL, Curran PJ, Mueser KT. Factor structure and construct validity of the Scale for the Assessment of Negative Symptoms. Psychol Assess. 1996;8:269-289.
25. White L, Harvey PD, Opler L, Lindenmayer JP. Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. A multisite, multimodel evaluation of the factorial structure of the Positive and Negative Syndrome Scale. The PANSS Study Group. Psychopathology. 1997;30:263-274.
26. van der Gaag M, Cuijpers A, Hoffman T, et al. The fivefactor model of the Positive and Negative Syndrome Scale I: confirmatory factor analysis fails to confirm 25 published five-factor solutions. Schizophr Res. 2006;85:273-297.
27. Harvey PD, Koren D, Reichenberg A, Bowie CR. Negative symptoms and cognitive deficits: what is the nature of their relationship? Schizophr Bull. 2006;32:250-258.
28. Berridge KC, Robinson TE. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev. 1998;28:309-369. (Pubitemid 29012677)
29. Knutson B, Fong GW, Adams CM, Varner JL, Hommer D. Dissociation of reward anticipation and outcome with eventrelated fMRI. Neuroreport. 2001;12:3683-3687. (Pubitemid 33105151)
30. Schultz W. Getting formal with dopamine and reward. Neuron. 2002;36:241-263. (Pubitemid 35217890)
31. Wise RA. Brain reward circuitry: insights from unsensed incentives. Neuron. 2002;36:229-240. (Pubitemid 35217889)
32. Gard DE, Germans-Gard M, Kring AM, John OP. Anticipatory and consummatory components of the experience of pleasure: a scale development study. J Pers. 2006;40:1086-1102. (Pubitemid 44712586)
33. Kring AM, Caponigro JM. Emotion in schizophrenia: where feeling meets thinking. Curr Dir Psychol Sci. 2010;19:255-259.
34. Gard DE, Kring AM, Gard MG, Horan WP, Green MF. Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure. Schizophr Res. 2007;93:253-260. (Pubitemid 46817952)
35. Juckel G, Schlagenhauf F, Koslowski M, et al. Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics. Psychopharmacology (Berl). 2006;187:222-228. (Pubitemid 44015616)
36. Favrod J, Ernst F, Giuliani F, Bonsack C. Validation of the Temporal Experience of Pleasure Scale (TEPS) in a Frenchspeaking environment. Encephale. 2009;35:241-248.
37. Chan R C K, Wang Y, Huang J, et al. Anticipatory and consummatory components of the experience of pleasure in schizophrenia: cross-cultural validation and extension. Psychiatry Res. 2010;175:181-183.
38. Horan W, Green M, Kring A, Nuechterlein K. Does anhedonia in schizophrenia reflect faulty memory for subjectively experienced emotions? J Abnorm Psychol. 2006;115:496-508. (Pubitemid 44763680)
39. Herbener E. Emotional memory in schizophrenia. Schizophr Bull [serial online]. 2008;34:875-887.
40. Horan WP, Kring AM, Blanchard JJ. Anhedonia in schizophrenia: a review of assessment strategies. Schizophr Bull. 2006;32:259-273.
41. Bellack AS, Sayers M, Mueser KT, Bennett M. Evaluation of social problem solving in schizophrenia. J Abnorm Psychol. 1994;103:371-378. (Pubitemid 24152810)
42. Hooley JM. Expressed emotion and relapse of psychopathology. Annu Rev Clin Psychol. 2007;3:329-352. (Pubitemid 46651132)
43. Corrigan P. How stigma interferes with mental health care. Am Psychol. 2004;59:614-625. (Pubitemid 39442875)
44. Grant PM, Beck AT. Defeatist beliefs as a mediator of cognitive impairment, negative symptoms, and functioning in schizophrenia. Schizophr Bull. 2010;35:798-806.
45. Blanchard JJ, Horan WP, Collins LM. Examining the latent structure of negative symptoms: is there a distinct subtype of negative symptom schizophrenia? Schizophr Res. 2005;77:151-165. (Pubitemid 41112209)
46. Foussias G, Remington G. Negative symptoms in schizophrenia: avolition and Occam's razor. Schizophr Bull. 2010;36:359-369.
47. Green MF, Nuechterlein KH, Gold JM, et al. Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry. 2004;56:301-307. (Pubitemid 39164514)
48. Horan WP, Rassovsky Y, Green MF. Stimulating development of new drugs to improve cognition in schizophrenia. Current Psychosis and Therapeutics Reports. 2005;3:68-73.
49. Kirkpatrick B, Strauss GP, Nguyen L. The brief negative symptom scale: psychometric properties. Schizophr Bull. June 28, 2010; doi: 10.1093/schbul/sbq059.
50. Blanchard JJ, Mueser KT, Bellack AS. Anhedonia, positive and negative affect, and social functioning in schizophrenia. Schizophr Bull. 1998;24:413-424. (Pubitemid 28378226)
51. Blanchard JJ, Horan WP, Brown SA. Diagnostic differences in social anhedonia: a longitudinal study of schizophrenia and major depressive disorder. J Abnorm Psychol. 2001;110:363-371. (Pubitemid 32703074)
52. Kring A, Barrett L, Gard D. On the broad applicability of the affective circumplex: representations of affective knowledge among schizophrenia patients. Psychol Sci. 2003;14:207-214. (Pubitemid 37282428)
53. Kirkpatrick B, Buchanan R. Anhedonia and the deficit syndrome of schizophrenia. Psychiatry Res. 1990;31:25-30. (Pubitemid 20049541)
54. Kring AM, Moran EK. Emotional response deficits in schizophrenia: insights from affective science. Schizophr Bull. 2008;34:819-834.
55. Horan WP, Blanchard JJ. Emotional responses to psychosocial stress in schizophrenia: the role of individual differences in affective traits and coping. Schizophr Res. 2003;60:271-283. (Pubitemid 36184715)
56. Niv N, Cohen A, Mintz J, Ventura J, Young A. The validity of using patient self-report to assess psychotic symptoms in schizophrenia. Schizophr Res. 2007;90:245-250. (Pubitemid 46178539)
57. Depue R, Morrone-Strupinksy JV. A neurobehavioral model of affiliative bonding: implications for conceptualizing a human trait of affiliation. Behav Brain Sci. 2005;28:313-395.
58. Gable SL. Approach and avoidance social motives and goals. J Pers. 2006;74:175-222.
59. Kelley HH, Berscheid E, Christensen A, et al. Close Relationships. New York, NY: Freeman; 1983.
60. Reis H, Collins WA, Berscheid E. The relationship context of human behavior and development. Psychol Bull. 2000;126:844-872.
61. Ryan RM, Deci EL. Self-determination theory and the facilitation of intrinsic motivation, social development, and well-being. Am Psychol. 2006;55:68-78.
62. Forbes C, Blanchard JJ, Bennet ME, et al. Initial development and preliminary validation of a new negative symptom measure: the clinical assessment interview for negative symptoms (CAINS). Schizophr Res. 2010; doi:10.1016/j.schres.2010.08.039.